碘苯酯加抗癌药经肝动脉治疗原发性肝癌  

Hepatic Intraarterial Injection of Myodil and Anticancer Drug in the Treatment of Hepatocellular Carcinoma

作　　者：黄迪生[1] 黄求里 李木生[1] 曾祥龙 姜毅竖 徐辉华 

机构地区：[1]四川绵阳市中心医院 [2]绵阳市肿瘤医院

出　　处：《实用放射学杂志》1991年第3期132-134,T157,共4页Journal of Practical Radiology

摘　　要：碘苯酯加抗癌药栓塞治疗30例(51次)原发性肝癌。经栓塞治疗后大多数病员肿瘤有所回缩。随访6月生存率为64％,而24％患者生存率超过1年。本法不仅对肝癌治疗有效并可观察HAI后肿瘤形态改变,分阶段治疗可避免肝功能衰竭,重复治疗可延长生存率,只要不是很严重的门静脉癌栓,仍可使用肝动脉栓塞。30 cases of primary liver cancer were treated by a total of 51 times of intra-hepatic artery injection of myodil and anticancer drugs. Most patients showed a reduction in tumor size after this procedure. The patients had been followed. Six-month survival rate was 64%. 24% of patients had beensurvived for more than one year. This method is considered to be both effective for treatment and convenient in evaluation of post-HAE changes in the lesion. Fractionated therapy may be used to avoid the development of hepatic insufficiency and surviving period was prolonged. HAE might be considered when portal vein embolization is not serious.

关 键 词：碘苯酯 肝动脉 肝肿瘤 抗癌药物 

分 类 号：R735.705[医药卫生—肿瘤]